|
本期重點主題
l SGLT2 抑制劑可能誘發生殖器部位罕見嚴重感染症
l Vildagliptin, Sofosbuvir/Ledipasvir 藥品健保給付規定異動
l 水果與藥物交互作用 |
107年10月藥訊
Written by ○
Created: Tuesday, 25 September 2018 11:13
COM_CONTENT_MODIFIED_BY Last Updated: Tuesday, 25 September 2018 11:20
Hits: 2557
COM_CONTENT_MODIFIED_BY Last Updated: Tuesday, 25 September 2018 11:20
Hits: 2557


